
Teva: Though a Surprise, Departure of R&D Leader Shouldn't Take the Growth Momentum Off-Course
Teva announced the departure of Dr. Eric Hughes, Global R&D and Chief Medical Officer. David Gardiner, Head of Innovative Medicines & Clinical Development, will serve in the interim, while Hughes will remain with the firm through the coming months to support the leadership transition.